NCT02246881 - A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A. | Biotech Hunter

Timeline

Start Date

October 31, 2001

Primary Completion Date

January 31, 2004

Conditions

Von Willebrand Disease

Interventions

BIOLOGICAL

Optivate® (Human Coagulation Factor VIII)

Trial Locations (8)

Klinika Haematologii, Akademia Medyczna w Gdansku, ul., Debinki 7, 80-211 Gdansk

Klinika Haematologii, Akademia Medyczna w Lublinie, ul., Dr K Jaczewskiego 8, 20-090, Lublin

Klinika Haematologii, Akademia Medyczna w Lodzi, ul., Pabianicka 62, 93-513 Lodz

Haemophilia Centre, Addenbrooke's Hospital, Hills Road, Cambridge

Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard, Nottingham

Sheffield Haemophilia & Thrombosis Centre, Royal Hallamshire Hospital, Glossop Road, Sheffield

Haemophilia Centre, University Dept. of Haemophilia, Manchester Royal Infirmary, Manchester

Haemophilia Centre, Southampton General Hospital, Tremona Road, Southampton